RxDoctor Payments Data

Aleksandr Emerel

Foot & Ankle Surgery · Malvern, PANPI 1508283029

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Synthes USA Products LLC at 37.6% of the total. Reporting peaked in 2021 at $18,860 and has fallen 65.4% since, to $6,524 in 2025. Among foot & ankle surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,339in general payments, 2019–2025

Across 204 payments — averaging $261.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes USA Products LLC$20K
  • Paragon 28, Inc.$12K
  • Medical Device Business Services, Inc.$9K
  • Arthrex$5K
  • Johnson & Johnson$2K
  • Liberty Surgical Inc.$1K
  • plus $4K from 24 others

What the payments were for

  • Consulting fees$31,34059%
  • Speaking & faculty fees$1,2502%
  • Travel & lodging$10,58520%
  • Food & beverage$7,62514%
  • Education$2,5395%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,339 in reported general payments places this provider in the 95th percentile of 575 foot & ankle surgery providers in Pennsylvania.

See all foot & ankle surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$149,217
Medicare patients
420
Services billed
1,717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl18$234
Methylprednisolone29$139
Cephalexin34$112
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$78
Doxycycline Hyclate13$66
Tramadol Hcl16$28
Meloxicam12$10

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Malvern

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →